The following is a summary of “Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory ...

The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the signaling of interleukin (IL)-31.

As everyone knows, scratching at chronically itchy skin only makes the problem worse. A new device is claimed to help stop ...

Sanofi SNY and partner Regeneron REGN announced that the FDA has accepted their supplemental biologics license application ...

Discover a study where findings revealed that using the new device significantly decreased both total and hourly scratch ...

Astria advances innovative therapies for hereditary angioedema and atopic dermatitis. Strong cash position supports pivotal ...

Jason B. Pieper, DVM, MS, DACVD, talks about the multiple therapies available for cases of moderate and severe atopic dermatitis and delves into each option ...

The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate ...

Treating eczema starts with a solid skincare routine, but you may need more than just moisturizer to get you through a flare-up.

Long-term lebrikizumab was effective for atopic dermatitis treatment in patients who did not have adequate response to short-term treatment.

A 0.15% once-daily roflumilast cream improved symptoms of atopic dermatitis (AD) across multiple endpoints, according to ...